Glomerular volume and clinicopathologic features related to disease severity in renal biopsies of African Americans and whites in the southeastern United States

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 11, 2007, Pages 1665-1672

  Hughson, Michael D ^a   Samuel, Terence ^b   Hoy, Wendy E ^c   Bertram, John F ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE SEVERITY; EUROPEAN AMERICAN; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOMEGALY; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; MALE; OBESITY; RACE DIFFERENCE; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; BIOPSY; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 35948981739     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Smith SR, Svetky LP, Dennis VW. Racial differences in the incidence and progression of renal disease. Kidney Int. 1991;40:815-822.
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. JAMA 1997;227:1293-1298.
3. United States Renal Data System, 1996 annual data report. Am J Kidney Dis. 1996;28(suppl 3):S1-S151.
4. Mississippi State Department of Health. The epidemiology of end-stage renal disease in Mississippi. Miss Morb Rep. 1999;18:1-2.
5. Pesce CM, Schmidt K, Fogo A, et al. Glomerular size and the incidence of renal disease in African Americans and Caucasians. J Nephrol. 1994;7:355-358.
6. Schmidt K, Pesce C, Liu QL, et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol. 1992;3:229-235.
7. Abdi R, Slakey D, Kittur D, Racusen L. Heterogeneity of glomerular size in normal donor kidneys: impact of race. Am J Kidney Dis. 1998;32:43-46.
8. Bertram JF, Young RJ, Seymour AE, Kincaid-Smith P, Hoy W. Glomerulomegaly in Australian aborigines. Nephrology. 1998;4(suppl iii-iv):S46-S53.
9. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis. 1994;23:171-175.
10. Broyer M, Soto B, Gagnadoux M-F, Adi M, Rica C, Gubler M-C. Oligomeganephronic renal hypoplasia. Adv Nephrol. 1997;26:47-63.
11. Esposito C, He C-J, Striker GE, Zalups RK, Striker LJ. Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol. 1999;154:891-897.
12. Olson JL, Heptinstall RH. Biology of disease: non-immunological mechanisms of glomerular injury. Lab Invest. 1988;59:564-578.
13. Fogo A, Hawkins EP, Berry PL, et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerulosclerosis. Kidney Int. 1990;38:115-123.
14. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure, less of one, more of the other? Am J Hypertension. 1988;1:335-347.
15. Young RJ, Hoy WE, Kincaid-Smith P, Seymour AE, Bertram JF. Glomerular size and glomerulosclerosis in Australian Aborigines. Am J Kidney Dis. 2000;36:481-489.
16. Fogo A, Ichikawa I. Evidence for a pathogenic link between glomerular hypertrophy and sclerosis. Am J Kidney Dis. 1991;17:666-669.
17. Adelman RD, Restaino IG, Alon US, Blowey DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr. 2001;138:481-485.
18. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498-1509.
19. Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2001;16:1790-1798.
20. Kasiske BL, Crossom JT. Renal disease in patients with massive obesity. Arch Intern Med. 1986;146:1105-1109.
21. Verani RR. Obesity associated focal segmental glomerulosclerosis: pathologic features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis. 1992;20:629-634.
22. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemic of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
23. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368-382.
24. Weibel ER, Gomez DM. A principle for counting tissue structures on random sections. J Appl Physiol. 1962;17:343-348.
25. Bertram JF. Analyzing renal glomeruli with the new stereology. Int Rev Cytol. 1995;161:111-172.
26. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143.
27. Hoy W, Samuel T, Hughson MD, Nicol JL, Bertram JF. How many glomerular profiles need to be measured to obtain reliable estimates of mean glomerular area in human renal biopsies? J Am Soc Nephrol. 2006;17:556-563.
28. Levey AS, Coresh J, Greene T, et al, for the Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254.
29. Rodriquez-Iturbe B, Johnson RJ, Herra-Acosta J. Tubulointerstitial damage and progression of renal failure. Kidney Int. 2005;68:S82-S86.
30. Javaid B, Olson JL, Meyer TW. Glomerular injury and tubular loss in adriamycin nephrosis. J Am Soc Nephrol. 2001;12:1391-1400.
31. United States Renal Data System, 2005 annual data report. Am J Kidney Dis. 2005;47(suppl 1):S1-S286.
32. Korbet SM, Genchi RM, Borok RZ, Schwartz MM. The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis. 1996;27:647-651.
33. Kitiyakara C, Eggers P, Kopp JB. Twenty-one year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 2004;44:815-828.
34. Bastian HM, Roseman JM, McGwin G Jr, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XII: risk factors for lupus nephritis after diagnosis. Lupus. 2002;11:152-160.
35. Alarcon GS, McGwin G Jr, Petri M, Reveille ID, Ramsey-Goldman R, Kimberly RP, for the PROFILE Study Group. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus. 2002;11:95-101.
36. Cooper GS, Parks CG, Treadwell EL, et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the Southeastern United States. Lupus. 2002;11:161-167.
37. Contreras G, Lenz O, Pardo V, et al. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int. 2006;69:1846-1851.
38. Samuel T, Hoy WE, Douglas-Denton R, Hughson MD, Bertram JF. Determinants of glomerular volume in different cortical zones of the human kidney. J Am Soc Nephrol. 2005;16:3102-3109.
39. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE. Hypertension, glomerular number, and birth weight in African Americans and whites in the southeastern United States. Kidney Int. 2006;69:671-678.
40. Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int. 2003;63(suppl 83):S31-S37.
41. Hughson M, Farris AB, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and glomerular size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003;63:2113-2122.
42. Hughson MD, Johnson K, Young RJ, Hoy WE, Bertram JF. Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and glomerular obsolescence. Am J Kidney Dis. 2002;39:679-688.
43. Remuzzi A, Mazerska M, Gephardt GN, Novick AC, Brenner BM, Remuzzi D. Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int. 1995;48:155-162.
44. Lane PH. Methods in laboratory in vesical ions: determination of mean glomerular volume in nephrectomy specimens. Lab Invest. 1995;72:765-770.
45. Lane PH, Steffes MW, Mauer SM. Estimation of glomerular volume: a comparison of four methods. Kidney Int. 1992;41:1085-1089.
46. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension and Detection Follow-up Program. Am J Kidney Dis. 2005;46:587-594.
47. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871-880.
48. Ejerblad E, Fored CM, Linblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17:1695-1702.
49. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453-1459.